Germany Syringe Market Forecasts Report 2024: A $489.4 Million Market by 2029 Featuring Major Players - BD, B. Braun Melsungen, Terumo, Teleflex, Nipro, ICU Medical, and Cardinal Health
Express News | Citigroup Maintains Neutral on Cardinal Health, Lowers Price Target to $107
Cardinal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 11.95% Citigroup $115 → $107 Maintains Neutral 07/09/2024 9.86% Evercore ISI Group $115 → $105
Cardinal Health (NYSE:CAH) Shareholders Have Earned a 20% CAGR Over the Last Five Years
Cardinal Health, Inc. (NYSE:CAH) shareholders might be concerned after seeing the share price drop 12% in the last quarter. But that doesn't change the fact that the returns over the last five
Citigroup Adjusts Price Target on Cardinal Health to $107 From $115, Neutral Rating Maintained
Cardinal Health (CAH) has an average hold rating and a price target range of $92 to $130, according to analysts polled by Capital IQ.
Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Cuts Target Price to $107
Citi analyst Daniel Grosslight maintains $Cardinal Health(CAH.US)$ with a hold rating, and adjusts the target price from $111 to $107.According to TipRanks data, the analyst has a success rate of 50.4
Express News | Cardinal Health Inc : Citigroup Cuts Target Price to $107 From $115
Leerink Partners Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $122
Leerink Partners analyst Michael Cherny maintains $Cardinal Health(CAH.US)$ with a buy rating, and adjusts the target price from $120 to $122.According to TipRanks data, the analyst has a success
Cardinal Health: Navigating Inflation With Strategic Mitigation – Outperform Rating & $122 Target
Why the Market Dipped But Cardinal Health (CAH) Gained Today
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report
How Is The Market Feeling About Cardinal Health?
Cardinal Health's (NYSE:CAH) short percent of float has fallen 17.69% since its last report. The company recently reported that it has 6.12 million shares sold short, which is 3.35% of all regular
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Raises Target Price to $95
Wells Fargo analyst Steve Baxter maintains $Cardinal Health(CAH.US)$ with a sell rating, and adjusts the target price from $94 to $95.According to TipRanks data, the analyst has a success rate of 51.6
Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH) and Apellis Pharmaceuticals (APLS)
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Cuts Target Price to $105
Evercore analyst Elizabeth Anderson CFA maintains $Cardinal Health(CAH.US)$ with a hold rating, and adjusts the target price from $110 to $105.According to TipRanks data, the analyst has a success
Evercore ISI Adjusts Cardinal Health's Price Target to $105 From $115, Keeps In Line Rating
Cardinal Health (CAH) has an average rating of hold and price targets ranging from $92 to $130, according to analysts polled by Capital IQ.Price: 97.73, Change: +0.85, Percent Change: +0.88
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $130
Baird analyst Eric Coldwell maintains $Cardinal Health(CAH.US)$ with a buy rating, and adjusts the target price from $128 to $130.According to TipRanks data, the analyst has a success rate of 52.5%